CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
29.95
+0.59 (2.01%)
At close: Feb 4, 2025, 4:00 PM
31.02
+1.07 (3.57%)
After-hours: Feb 4, 2025, 4:47 PM EST
CG Oncology Employees
CG Oncology had 61 employees as of December 31, 2023.
Employees
61
Change
n/a
Growth
n/a
Revenue / Employee
$11,213
Profits / Employee
-$1,290,672
Market Cap
2.28B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 61 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
CGON News
- 7 weeks ago - CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 7 weeks ago - CG Oncology: Positive Phase 3 Outcome Could Lead To BLA Of Cretostimogene - Seeking Alpha
- 7 weeks ago - CG Oncology Announces Pricing of Public Offering - GlobeNewsWire
- 2 months ago - CG Oncology Announces Proposed Public Offering - GlobeNewsWire
- 2 months ago - Health Rounds: Experimental CG Oncology immunotherapy shows promise in bladder cancer - Reuters
- 2 months ago - SUO-CTC and CG Oncology Announce the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award - GlobeNewsWire
- 2 months ago - Groundbreaking Cretostimogene Grenadenorepvec Monotherapy Data Demonstrates Sustained, Durable Complete Responses in High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - GlobeNewsWire
- 5 months ago - CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - GlobeNewsWire